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Abstract
Increased tolerance to antimicrobial agents is thought to be an important feature of microbes growing in biofilms. We
address the question of how biofilm organization affects antibiotic susceptibility. We established Escherichia coli biofilms
with differential structural organization due to the presence of IncF plasmids expressing altered forms of the transfer pili in
two different biofilm model systems. The mature biofilms were subsequently treated with two antibiotics with different
molecular targets, the peptide antibiotic colistin and the fluoroquinolone ciprofloxacin. The dynamics of microbial killing
were monitored by viable count determination, and confocal laser microscopy. Strains forming structurally organized
biofilms show an increased bacterial survival when challenged with colistin, compared to strains forming unstructured
biofilms. The increased survival is due to genetically regulated tolerant subpopulation formation and not caused by a
general biofilm property. No significant difference in survival was detected when the strains were challenged with
ciprofloxacin. Our data show that biofilm formation confers increased colistin tolerance to cells within the biofilm structure,
but the protection is conditional being dependent on the structural organization of the biofilm, and the induction of
specific tolerance mechanisms.
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Introduction
Natural conjugative plasmids express factors that can stimulate
planktonic bacteria to form biofilm communities [1]. Biofilm
formation also favors the infectious transfer of plasmids [2,3], and
many medically relevant microbial pathogens are often associated
with a variety of conjugative plasmids indicating an increased
tendency for biofilm formation [1,4–6]. Microbial biofilms are
notoriously hard to treat with antimicrobial compounds. The
molecular nature of this apparent resistance is not well elucidated
and a number of mechanisms have been proposed to explain the
reduced susceptibility [7]. The architecture of mature biofilms
varies considerably from flat homogenous layers of cells to highly
organized cell clusters characterized by mushroom shaped
structures interspersed by water-filled channels [8]. The organi-
zation of the biofilm affects the distribution of chemical and
physiological gradients within the microbial assembly, which in
turn affects the metabolic state of the bacteria, resulting in a
heterogeneous congregation of cells in different physiological states
[8–10]. The spatial and physiological heterogeneity of the biofilm
architecture has the potential to affect the antimicrobial tolerance
profiles of the organisms in the biofilm by forming microhabitats
with diverse properties [11].
Escherichia coli (E.coli) K12 strains usually form unstructured flat
biofilms in comparison with the highly organized and substantial
biofilms formed by bacteria such as Pseudomonas aeruginosa
(P.aeruginosa) [6,12]. Introduction of transfer constitutive IncF
plasmids dramatically changes the organization of E.coli biofilms to
a structure resembling those reported for P.aeruginosa [1,6]. Biofilm
organization is determined by the configuration of the transfer pili
since various mutants affected in the processing and activity of the
pili exhibit differentially structured biofilms [6].
The ability to survive exposure to cationic antimicrobial
peptides is an essential virulence property for many microbial
pathogens [13]. Antimicrobial peptides are an integral part of the
host defense system and believed to kill microorganisms by
affecting their membrane integrity. Colistin is an amphipathic
polypetide antibiotic utilized in the treatment of multi-resistant
P.aeruginosa causing chronic pulmonary infections among cystic
fibrosis patients. The peptide antibiotic is also extensively used
both as feed additive and in the treatment of severe colibacillosis
caused by pathogenic E.coli in livestock [14,15]. Resistance
towards antimicrobial peptides such as colistin is seldom identified
in the clinical setting [16]. Gram-negative bacteria have evolved
mechanisms that remodel the composition of the outer membrane
through modification of the lipopolysaccharide (LPS) molecules
[13]. The modifications lead to an increased tolerance to
antimicrobial peptide exposure, and is controlled by a two-
component regulatory system encoded by homologs to the
Salmonella typhimurium pmrA/B genes in many bacterial species
[17,18]. LPS alterations are thought to play a significant role
during infection by conferring increased bacterial tolerance to host
antimicrobial factors and avoidance of immune system recognition
[13].
In contrast to colistin, the primary E.coli target for fluoroquin-
olone antibiotics such as ciprofloxacin is the topoisomerase II
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Resistance to fluoroquinolones in E. coli occurs by chromosomal
mutation and requires alterations in either of the genes that
encode the topoisomerases (gyrA and gyrB, encoding gyrase, and
parC and parE, encoding topoisomerase IV) or in genes that
influence cell permeability or drug export [20,21].
In this report, we challenge E.coli biofilms with differential
structural organization with colistin or ciprofloxacin, two clinically
relevant antibiotics with different molecular targets and mechanisms
of resistance. We show that biofilm formation increases the survival
of the microbes after challenge by the peptide antibiotic but not by
the fluoroquinolone. The increased survival is dependent on the
basR/basS (pmrA/B) two-component system, since disruption of their
encoding genes abolishes the observed protective effect while not
affecting the organization of the biofilm. We demonstrate that the
increased survival is due to development of a tolerant subpopulation
within the biofilm and that the formation of the subpopulation is
influenced by the spatial organization of the biofilm indicating that
intra-biofilm physiochemical gradients promote antibiotic tolerance
within spatially structured environments.
Results
E.coli cells in biofilms differing in organization display
differential survival after colistin treatment
The presence of transfer constitutive IncF plasmids fundamen-
tally influences the architecture and organization of E.coli biofilms
[6]. The final spatial arrangement of the biofilm is determined by
the configuration of the transfer pili, as various mutants in the
processing and activity of the organelle display differentially
organized biofilms [6]. F pilus synthesis requires 13 essential genes
and 4 auxiliary genes of plasmid origin. TraQ is required for
insertion of propilin (TraA) in the inner membrane. Absence of the
TraQ chaperone results in rapid degradation of TraA in the
cytoplasm [22]. TraX is responsible for acetylation of the N-
terminus of mature pilin, but the modification is non-essential for
pilus elaboration and transfer proficiency [23,24]. TraD is not
involved in pilus assembly but instead has an essential role in DNA
transfer at a stage following cell/cell contact [25]. To study the
effects of differential biofilm organization in relation to antibiotic
tolerance, we established a static biofilm and survival assay of
wildtype, traQ, traX, and traD mutant derivatives of pOX38 [26] in
E.coli K12 CSH26 derivative SAR18, which were compared with
biofilms formed by plasmid-free SAR18 in standard flat-bottomed
96 well microtiter dishes. The strains were inoculated in Luria
broth and incubated statically for 24h. Differential biomass
accumulation for SAR18 F
+ and the various mutants compared
to SAR18 was confirmed by crystal violet staining of the wells
(Fig. 1A). The results were consistent with the previously observed
biofilm phenotype in the flow-chamber biofilm system. SAR18F
+,
F
+(traD) and F
+(traX) accumulate increased amounts of biomass in
microtiter wells compared to SAR18F
+(traQ) and SAR18 lacking
F
+ (Fig. 1A) [6]. For the colistin survival assay, the established
biofilms were challenged with 10 mg/ml of the cationic antimi-
crobial peptide colistin instead of washing and crystal violet
staining [27]. The killing activity and mode of action of
antimicrobial peptides is highly influenced by experimental
conditions and bacterial cell number [28].To keep the experi-
mental conditions as comparable as possible the antibiotic was
added directly to the wells without prior washing and removal of
putative planktonic cells. After an additional 24h incubation with
antibiotic, the total surviving CFU were determined by serial
dilution and plating on culture media by dislodging the biofilms
from the microtiter wells by vigorous aspiration. We observed a
three fold difference in survival between SAR18 and SAR18 F
+,
where the surviving CFU were significantly elevated in SAR18 F
+
biofilms (Fig. 1B) (P,0.0044). Survival was even more enhanced
in the biofilm produced by the traD mutant where the difference
was five fold compared to SAR18 (Fig. 1B). Survival did not
correlate with the amount of biofilm biomass formed because the
traX mutant, that forms biofilm in a quantity approximately equal
to the traD mutant, did not show any enhanced survival (Fig. 1B).
The presence of the F derivatives did not affect colony forming
unit (CFU) formation in the wells since no difference in CFU
counts could be detected in untreated control wells (Fig. 1B and C)
(P.0.05). Addition of the fluoroquinolone ciprofloxacin (0.3 mg/
ml), an antibiotic with an intracellular target, showed no
significant difference in killing of the different strains (Fig. 1C)
(P.0.05). The MIC for colistin and ciprofloxacin were 1 mg/ml
and 0.03 mg/ml, respectively, for all of the strains in the study.
Mutations in the transfer operons do not confer
protection in plantonic cultures
Mutations in the transfer operon may have important pleiotropic
consequences independent of the biofilm context, we therefore
investigated the survival after colistin and ciprofloxacin treatment of
planktonic cultures to the of wildtype, traQ, traX,a n dtraD mutant
derivatives of pOX38 and plasmid-free SAR18 biofilmcultures. The
strains were inoculated in Luria broth using standard polystyrene
culture tubes and incubated under shaking (rpm 220) conditions for
24 h. The cultures were then challenged with 10 mg/ml colistin for
an additional 24h and surviving colony-forming units (CFU) were
determined by serial dilution and plating on culture media. For all
strains approximately 3610
7 CFU had survived the colistin
challenged, while the untreated control cultures had reached a
CFU of 1610
9. There was no significant (P.0.05) difference in
survival between wildtype, traQ, traX,a n dtraD mutant derivatives of
pOX38 and plasmid-free SAR18 biofilm cultures (Fig. 1D). If the
shaken over night cultures instead were challenge with 0.3 mg/ml
ciprofloxacin for 24 h, 2610
6 CFU were detected corresponding to
a 3 log difference of survival between the different growth model
systems (Fig. 1D). These data indicate that the presence of the F
plasmidanditsmutantderivativesdoesnotaffectantibiotictolerance
during planktonic growth.
The increased survival of cells in colistin treated biofilms
is dependent on a functional basS gene
The E.coli K12 strain MG1655 is better characterized genetically
than the SAR18 strain. Moreover, SAR18 harbors a number of
antibioticresistancemarkersthatmakegeneticmanipulationdifficult
(Table 1). We included the strain AF504, a nalidixic acid resistant
derivative of MG1655, and a curli over-producing ompR234 mutant
of MG1655 in the investigation. Curli overproduction results in
increased biofilmformation inthebiofilmflowchamber systeminan
F-plasmid independent manner [6]. To investigate if the observed
increase in colistin tolerance of biofilm cells is genetically determined
or due to a generic difference in biofilm permeability, we introduced
insertion deletions into the basS gene of AF504, using one-step allelic
replacement [29]. We established biofilms of these mutant strains
and compared the survival of the bacteria with or without the F-
plasmid and its mutant traD variant after colistin treatment. As
expected, introduction of the F-plasmid or its traD mutant derivative
into AF504 drastically increased biofilm formation as well as colistin
tolerance of the resulting strains (Fig. 2A and B). The protective
effect of biofilm formation with F
+ and F
+(traD) was completely
abolished in the basS mutants, and the survival reached a level
comparable to the survival of plasmid free AF504 (Fig. 2B). If the
Biofilm Antibiotic Tolerance
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the basS traD mutant biofilm protection was restored (Fig. 2B), while
if the same plasmid was introduced into AF504 or AF504 F
+(traX)n o
effect on survival could be detected (Fig. 2B). If the vector alone was
introduced to the strains, no effect on biofilm formation or survival
could be detected (data not shown). The nalidixic acid resistance of
AF504 does not affect the outcome of the biofilm survival assay since
there is no detectable difference in survival between MG1655 and
AF504 after colistin challenge (data not shown). These results
indicate that a specificgenetic mechanism isunderlying the observed
increased tolerance in biofilm forming E.coli. Over-expression of the
curli fimbriae drastically influences the biofilm development in E.coli
and such strains form biofilms comparable to the ones formed by
F
+(traD)a n dF
+(traX) mutants (Fig. 2A [6,30]. No increase in survival
after colistin treatment compared to the plasmid free AF504 was
detected, demonstrating that biofilm formation and survival after
antibiotic treatment are not directly correlated (Fig. 2B). If the same
basSmutationwasintroducedinto Sar18F
+,pilimediatedprotection
was abolished, showing that basS dependence is not exclusive for
AF504 (Fig. 1B). Increased concentrations of colistin decreased the
number of viable cells within the microtiter wells in a concentration
dependent manner. Colistin concentrations above 60 mg/ml
reduced the number of viable cells to below the detection level of
100 CFU/ml (Data not shown). The MIC for colistin for all of the
AF504 derived strains were 1 mg/ml in microtiter assay.
E.coli flow-chamber biofilms are sensitive to the cationic
antimicrobial peptide colistin
To be able to study biofilm formation in vitro in the
hydrodynamic continuous-flow biofilm model system [31] we
tagged AF504 F
+ with the green fluorescent protein (GFP) under
the control of a ribosomal promoter forming the strain AF504 gfp
Figure 1. E.coli cells in biofilms differing in organization display differential survival after colistin treatment. A). Microtitre plate biofilm
assay with the parental E. coli SAR18 in the presence and absence of the de-repressed IncF plasmid and mutants in the IncF plasmid (traD, traX, and
traQ,) stained with crystal violet. Values are normalized with respect to the mean of SAR18 F
+ (traD) set as 100% B). A microtitre plate biofilm
antibiotic tolerance assay, in which the indicated strains were challenged with 10 mg/ml colistin for 24h and bacterial survival determined by viable
count as indicated by white bars. Untreated control is indicted by black bars. C). Microtitre plate biofilm antibiotic tolerance assay, in which the
indicated strains were challenged with 0.3 mg/ml ciprofloxacin for 24h and bacterial survival determined by viable count as indicted by white bars.
Untreated control is indicated by black bars. D). The survival of planktonically cultured stationary phase E. coli SAR18 in the presence and absence of
the de-repressed IncF plasmid and mutants in the IncF plasmid (traD, traX, and traQ,) after a 24 h 10 mg/ml colistin or 0.3 mg/ml ciprofloxacin
challenge. Black bars indicate CFU in untreated culture while white bars indicate treated cells as specified in the figure.
doi:10.1371/journal.pone.0001891.g001
Biofilm Antibiotic Tolerance
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+. The flow chambers were seeded with the strain and incubated
for 48h at 30uC in glucose minimal medium. The mature biofilms
were then exposed to 25 mg/ml colistin for 0h (untreated control),
6.5h and 24h and stained with propidium iodide (PI) to distinguish
living GFP expressing cells and dead PI stained cells (Fig. 3 A, B
and C). The untreated control biofilm exhibited a few dead (red)
cells spread out through the biofilm (Fig. 3A) while the majority of
the cells in the treated biofilm were clearly dead after 24 h (Fig. 3
C). The killing activity of the colistin moved from the edge of the
microcolonies to the inner part as shown in time series image
capturing (Movie S1). The time series also confirmed that
detachment was absent or low under these conditions. To
determine the proportion of viable cells in the biofilm channels,
the biofilm was dislodged from the flow-channel and the CFU/ml
were determined and normalized by the OD450 value obtained
for each channel. The number of viable cells recovered from the
channel decreased from 10
9 to 10
3 CFU/OD450 in 24 hours of
treatment and reached 10
2 CFU/OD450 after 48 hours of drug-
exposure. The number of viable cells in the control channel
remained constant during the time of the experiment (10
9 CFU/
OD450). If 50 mg/ml colistin was used, an exposure for 24 h was
enough for complete eradication of the biofilm and indeed no
growth was observable after plating. If plasmid free AF504 gfp cells
were inoculated in the flow channel system a few scattered loosely
attached cells could be detected through the channel after 24 h
and after a 24 h, 25 mg/ml colistin challenge very few bacteria
could be detected (data not shown).
A colistin tolerant subpopulation is formed in mature E.
coli flow-chamber biofilms
E. coli mature biofilm cells are killed efficiently by colistin
through gradual penetration into the centre of the microcolonies
(Fig 3 A, B and C). However, in large microcolonies we observed a
surviving population gradually increasing in biomass during the
first 48 h after addition of colistin. This phenomenon was
observed using 10 mg/ml and 25 mg/ml colistin (Fig. 3D and E).
The tolerant subpopulation only formed in fully mature biofilms of
bacteria expressing the transfer pili and was able to re-develop into
a new biofilm if colistin free media was supplied to the flow
chamber system (Fig. 3F). One day after a shift from 25 mg/ml
colistin to antibiotic-free medium the tolerant population was
growing and after additional two days, microcolony formation and
biofilm re-development was observed (Fig. 3F).
Colistin tolerance is not due to resistance mutations
Based on these findings we wanted to investigate if the
developing colistin tolerant subpopulations were the results of
genetically mutated resistant cells, or if they represented
phenotypically tolerant variants. We isolated the biofilm material
from 2-day-old flow channel biofilms, grown in glucose minimal
media, which had subsequently been exposed to 10 mg/ml or
25 mg/ml colistin, for 24–48 h. The isolated biofilm samples were
homogenized and stained with PI after which individual cells were
Figure 2. The increased survival of cells in biofilms is dependent on a functional basS gene. A). Microtitre plate biofilm assay with the
parental E. coli AF504 in the presence and absence of the de-repressed IncF plasmid and mutants in the IncF plasmid (traD,), insertion deletions of the
basS and basR genes, and the curli overproducing opmR strain stained with crystal violet. Values are normalized with respect to the mean of AF504 F
+
(traD) set as 100%. B). A microtitre plate biofilm antibiotic tolerance assay in which the indicated strains were challenged with 10 mg/ml colistin for
24 h and bacterial survival determined. The fraction untreated/treated is indicated for each strain.
doi:10.1371/journal.pone.0001891.g002
Table 1. Bacterial strains used in this study.
Strains Description Reference
SAR18 CSH26 attB::bla-PA1/04/03gfpmut3*Cm
r [6]
AF504 MG1655 Nal
r ilvG, rfb-50, rph-1 This work.
AF504 gfp AF504 attB::bla-rrnBP1::gfpmut3b* This work
AF574 AF504 basS::cm This work
AF518 AF504 basS::kan This work
AF574 gfp AF504 basS::cm attB::bla-rrnBP1::gfpmut3b* This work
PHL 628 MG1655 ompR234 [63]
PHL 628 gfp PHL628 ompR234 attB::bla-rrnBP1::gfpmut3b* This work
XL10-Gold TetrD (mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1
supE44 thi-1 recA1gyrA96 relA1 lac Hte [F9 proAB
lacIqZDM15 Tn10 (Tetr) Amy Camr]
Stratagene
doi:10.1371/journal.pone.0001891.t001
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The red population was not viable as shown by plating on LB
plates whereas the green population was growing on LB plates, but
not on plates containing colistin (10 mg/ml or 25 mg/ml).
Development of a tolerant subpopulation in the biofilm after
treatment with colistin thus seems to be linked to adaptation or
activation of a surviving phenotype suggesting that a transiently
colistin tolerant subpopulation is formed in the biofilm. When the
cells were isolated from the flow chamber and re-grown without
colistin they lost the tolerance to the peptide and became sensitive
to the antibiotic, showing that the surviving tolerant cells were not
genetically resistant mutants selected in the flow chamber.
Colistin tolerance is correlated to biofilm structure and
architecture
To investigate the effect of biofilm architecture on antibiotic
susceptibility we established flow chamber biofilms with E.coli in
presence and absence of the de-repressed IncF plasmids (wildtype,
traD, traQ and traX). It has been previously shown that the tra
mutations lead to formation of biofilms with strikingly different
spatial distribution [6]. The different biofilms were treated with
colistin and the distribution of living and dead cells monitored.
Interestingly, strains with the de-repressed IncF WT plasmid and
the traD mutation forming biofilms with elaborate, rounded tower
structures rising from the confluent cell layer, displayed regions of
tolerant cells in the center of the biofilm micro-colonies after 24h
challenge with 10 mg/ml colistin. Moreover, this subpopulation
formation seemed to be more extensive in the traD mutant biofilm
compared to the wild type F
+ (Fig. 4A). The strains lacking the
IncF plasmid or carrying the traQ and traX mutant plasmids
formed biofilms with a less structured organization, and without
any recognizable mushroom shaped microcolony structures. In
these biofilms no observable tolerant subpopulation was detected
(Fig. 4A, data not shown). To evaluate the differences in bacterial
survival in the biofilms quantitatively, we analyzed the CLSM data
with the computer program COMSTAT [30]. The analysis
showed that approximately 35% of the cells survived in the biofilm
formed by SAR18 F
+(traD), while survival was significantly lower
(P,0.0030) for SAR18 F
+ biofilms, in which around 15% of the
cells were still green after 24h colistin treatment. In the biofilm
formed by SAR18 F
+(traX) less than 5% of the cells were viable
after colistin challenge which is significantly less than SAR18F
+
(P,0.0061). If the AF504 F
+(traD) were challenged with colistin in
the flow chamber system an extensive tolerant subpopulation was
observed while when the AF504 F
+(traX) strain no subpopulation
could be detected (data not shown).
Induction of colistin tolerance is basS dependent
The development of the tolerant subpopulation can be due to a
phenotypic change of the bacteria in the center of the large micro
colonies or to a generic difference in biofilm permeability. We
established flow chamber biofilms of E.coli AF504 F
+ with
additional chromosomal mutations in the basR/basS two-compo-
nent regulatory system. There was no measurable effect of the basS
mutation on biofilm structure, surface coverage and biomass as
determined by COMSTAT analysis (data not shown). No tolerant
subpopulation could be detected in the AF504 basS F
+ biofilms
after 24 h colistin treatment (Fig. 4B). COMSTAT quantification
of the acquired images clearly showed a significant difference in
the ratio between PI stained cells and GFP expressing cells in the
AF504 F
+ and the AF504 basS F
+ (data not shown) (P,0.0093).
These results suggest that subpopulation formation is genetically
regulated.
The yfbE gene is induced within structured biofilms prior
to colistin challenge
The ybf operon consists of seven genes (yfbE, F, G, H, arnT, yfbW
and J) that are implicated in the process of addition of the 4-
amino-4-deoxy-L-arabinose (L-Ara4N) moiety to the phosphate
groups of lipid A leading to increased polymyxin tolerance [32].
Figure 3. A colistin tolerant subpopulation is formed in mature E .coli flow-chamber biofilms. CLSM micrographs of a mature AF504 gfp/
F
+ biofilm after A) control, B) 6.5h; and C) 24h 25 mg/ml of colistin challenge. The biofilm was stained with PI at the specified time points before image
acquisition. Scale bars represent 50 mm D) CLSM micrograph showing the location of live (green) and dead (red) cells in E. coli AF504 gfp/F
+ biofilm
grown for 48 h and then exposed to 10 mg/ml of colistin for 24 h, an overview image taken with a 106objective. Scale bar represent 300 mm. E)
CLSM 3D micrograph image taken with a 406 objective of a single microcolony in the AF504 gfp/F
+ biofilm. F) CLSM micrograph 3D structure
showing the spatial distribution of living (green) and dead (red) cells of E. coli AF504 gfp/F
+ in a 6 days old biofilm, that has been grown in antibiotic
free media for 2 days and then exposed to 25 mg/ml colistin for 24 h and then switched back to antibiotic free medium.
doi:10.1371/journal.pone.0001891.g003
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2+ and high Fe
3+
is under the control of the basR/basS two-component system
[33,34]. To determine if tolerant subpopulation formation is
correlated with increased yfbE operon expression, we constructed a
plasmid harbouring the AF504 yfbE promoter in front of a
promoterless gfp gene and introduced it into our collection of
AF504 strains with differential biofilm formation ability. Expres-
sion of the yfbE::gfp reporter was induced when the strains were
grown in N-minimal media with 10 mM Mg
+2 and 100 mMF e
+3
relative to the expression levels when the strains were grown in
media with 10 mM Mg
+2(Fig. 5A). No increase in fluorescence
could be detected in strains, with a mutated basS gene, even when
they were cultivated under inducing conditions (Fig. 5A), and no
induction of the yfbE reporter could be detected by the addition of
colistin to the N-minimal media under low or high Mg
2+
conditions (data not shown). We then investigated GFP fluores-
cence of the different strains in microtiter biofilm assays. The
bacterial population in the microtiter wells is highly heterogeneous
and a direct measurement of the total fluorescence in the wells can
be misleading. Instead, we determined the proportion of cells in
the wells with elevated GFP fluorescence by using a strain with
constitutive GFP expression to determine maximum range
fluorescence and a strain with a promoterless vector control to
determine minimum fluorescence. The proportion of induced
fluorescent cells was significantly elevated in the biofilms formed
by the AF504 F
+ and AF504 F
+(traD) strains compared to the
biofilms formed by the wild type AF504 strain and the F
+(traX)
mutant (Fig. 5B). Interestingly, no increased fluorescence was
detected in strains harboring a basS mutation indicating that
observed increased fluorescence in the F
+ and F
+(traD) strains is
due to elevated yfbE expression, and that the induction occurs
prior to colistin challenge (Fig. 5B).
The yfbE::gfp reporter expression was also investigated in the
hydrodynamic flow chamber system. AF504 F
+ and AF504 basS F
+
strains were inoculated in the system and GFP expression
monitored after 24h our incubation without colistin treatment.
Green fluorescence could be detected in the centre of large micro
colonies in AF504 F
+ biofilm while no fluorescence could be
detected in basS mutant biofilm indictaing that there is a
correlation of yfbE expression and sub population formation in
flow chamber system (Fig. 5C).
Discussion
The formation of bacterial biofilms is often associated with a
reduced susceptibility to antimicrobial challenge [35,36]. The
mechanisms underlying the observed increased tolerance are
poorly elucidated and a direct causal relationship between
antibiotic tolerance development and biofilm formation is
inadequately supported [37,38]. Recently, Mah et. al. discovered
that periplasmic glucans interact with the aminoglycoside
tobramycin in P. aeruginosa biofilms and were proposed to delay
by sequestration the effect of the antibiotic [39]. P. aeruginosa also
has the ability to convert to an antibiotic-resistant phenotype after
antibiotic exposure with enhanced biofilm forming ability [40]. A
large proportion of the studies investigating biofilm tolerance are
comparisons between cultures grown under shaking conditions
(planktonic growth) and a particular biofilm model system [36,41–
49]. The result of this kind of comparisons can be misleading
because there are many other factors affecting antibiotic
susceptibility other than biofilm formation in these systems. Cell
number, growth phase, and media flow are factors that are varying
in the different growth systems and can potentially affect antibiotic
tolerance. There is a risk that results obtained under these
conditions more reflect differences between the particular growth
model systems rather than actually describing particular aspects of
biofilm physiology compared to planktonically grown cells. In
studies where tolerance has been investigated under physiologi-
cally similar conditions the differences in susceptibility has been
less dramatic [43,50]. To better understand the influence of
biofilm formation on the development of antibiotic tolerance, we
exploited the recent discovery of Reisner et al. [6] that biofilm
structure and organization can be manipulated by varying the
IncF transfer pilus configuration (Fig. 1 A). Using this set of
isogenic E. coli strains enable the investigation of antibiotic
tolerance and resistance under nearly identical physiological
conditions and the direct study of the influence of biofilm
formation on antibiotic tolerance rather than comparing different
growth model systems. We demonstrate that biofilm formation can
Figure 4. The colistin tolerance is influenced by biofilm
structural organization and tolerance induction is basS depen-
dent. A). CLSM micrographs showing the distribution of live and dead
cells in biofilms of the SAR18/F
+ (top left panel), SAR18/F
+(traD) (top
right panel), SAR18/F
+(traX) (bottom left panel), and PHL628 gfp
ompR234 (bottom right panel) after 24h challenge by 10 mg/ml colistin.
Scale bars represent 50 mm. B). CLSM micrographs showing the
distribution of live and dead cells in biofilms of AF504 gfp/F
+ (left
panel) and AF574 gfp basS::Kan/F
+ (right panel) mutant showing the
basS dependence of subpopulation formation after 24h challenge by
10 mg/ml colistin. Overview images taken with a 406 objective. Scale
bars represent 100 mm.
doi:10.1371/journal.pone.0001891.g004
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lenge, but the increased survival did not correlate directly with
biofilm forming ability as such, but rather depended on the
organization of the biofilm and on the antibiotic used (Fig. 1 and
2). When the biofilm forming strains were challenged with the
surface-active peptide antibiotic colistin, there was a dramatic
difference in survival between strains harboring the de-repressed
incF transfer pilus and the plasmid free strains (Figs. 1 and 2). In
contrast, when the biofilms were challenged with the fluoroquino-
lone ciprofloxacin, an antibiotic with an intracellular target, no
significant differences in survival were observed between the
investigated strains. Interestingly, resistance to ciprofloxacin is only
known to occur through chromosomal mutations in E. coli, while
antimicrobial peptide resistance and tolerance can arise through
both physiological and mutational mechanisms [20,21,34,51]. In
fact,ourdatasuggestthatphysiologicaltolerancemechanismmaybe
essential for the increased colistin tolerance of bacteria in biofilms.
When flow chamber biofilms with complex spatial organization
were challenged with colistin, subpopulations of tolerant cells were
observed, while no such populations were detected in biofilms with
flat, undifferentiated structure (Figs. 3 and 4). The localization of
the subpopulation in the center of the micro-colonies indicates that
the local environment within the biofilm induces subpopulation
formation in our experimental system. Tolerance development is
thus structurally dependent, influenced by the conditions created
within the biofilm. However, we do not believe our data directly
support a correlation of the difference in colistin tolerance to a
distinct spatial organization and it is important to make distinction
between a phenotype being structurally dependent and being
correlated with a specific structure. When mutations in basS were
introduced into the strains with wildtype F as well as the traD
mutant, survival was comparable to the strain without F (Fig. 2A).
Since basS is regulating the LPS modifications leading to
augmented antimicrobial peptide tolerance, these data show that
the increased survival is directly coupled to a genetically regulated
event. We show that the expression of the basR/S regulated yfbE
operon is up-regulated in the strains with increased survival and
subpopulation formation, when the strains are grown as biofilms
Figure 5. The yfbE gene is induced within structured biofilms prior to colistin challenge. A). Fluorescence of yfbE-gfp transcriptional fusion
expressed in bacteria grown in N-minimal media, pH 7.7, containing 38 mM glycerol with either 10 mM Mg
2+ (black bars), or 10 mMM g
2+ and
100 mMF e
3+ (white bars) Data shown are the average of three experiments. Mean fluorescence units were detected by using a Becton Dickingson
FACS Vantage SE cell sorter. Strains harboring the attB::bla-rrnBP1::gfpmut3b or the pJBA113 vector alone demonstrated constitutive fluorescence
and no fluorescence in all growth conditions, respectively. B). Fraction of fluorescent cells in the microtitre plate biofilm assay with the parental E. coli
AF504 in the presence and absence of the de-repressed IncF plasmid and mutants in the IncF plasmid (traD,), and the reciprocal insertion deletions of
the basS and basR genes, harboring the yfbE-gfp transcriptional fusion. The threshold for GFP fluorescence was cells with a value above 600 arbitrary
units. 99% of the constitutively expressing cells were above this threshold while 96% of the negative control was below. C). CLSM micrographs
showing the expression of the yfbE-gfp transcriptional fusion in flow chamber biofilms of AF504/F
+ (left panel) and AF574 basS/F
+ (right panel). Green
indicates GFP expressing cells all other cells appear red from treatment with SYTO62.
doi:10.1371/journal.pone.0001891.g005
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involved in the process of LPS modification, it is likely that it is
through this process that the tolerant subpopulation is formed
[32]. The increased expression of the operon occurs prior to
colistin addition, indicating that the subpopulation formation
process is not directly coupled to the addition of colistin or an
adaptation to the presence of antimicrobial peptide (Fig. 5B). The
main rational behind including the basRS mutant was to be able to
differentiate between the development of a generic biofilm induced
tolerance and specific genetic regulation to explain the observed
increased survival in the F
+ and F(traD) biofilms. Our data cannot
rule out that there are other basRS dependent resistance
mechanisms than LPS modification involved in the observed
phenomena. This possibility does not change the fact that colistin
tolerance is dependent on a specific genetic mechanisms rather
than a generic biofilm property.
When P. aeruginosa was challenged with colistin in the flow
chamber system, a tolerant subpopulation was also found [52]. In
contrast to E. coli, the surviving population was not observed in the
center of large micro colonies but rather on the surface of the
biofilm, and it was associated with a migrating cell population that
eventually colonized the top of the microcolonies, resulting in the
development of mushroom-shaped multicellular structures char-
acterizing P. aeruginosa flow chamber biofilms [52]. The P.
aeruginosa pmr system is known to be activated by the presence of
cationic antimicrobial peptides [53,54]. The yfbE homolog, pmrH,
was indeed induced in the migrating tolerant subpopulation when
the peptide was added to the system while cells in the stalks of the
mushroom-shaped micro colonies seemed unable to induce or
sense the presence of the peptide and were subsequently killed
[52]. It is also interesting to note that even though the cells in the
deeper layers of the flow chamber biofilm were coated by a thick
layer of tolerant cells, this was not able to protect these cells from
the action of the antibiotic [52]. No colistin-mediated induction
has been shown for E.coli, indicating a dissimilar regulation of
homologous genes responding to disparate environmental stimuli
since a migrating population is not present in the IncF mediated
biofilm. Even though the tolerant subpopulations form at different
locations within the E.coli and P.aeruginosa biofilms, there are
notable common features. Both populations require the presence
of genetically encoded tolerance mechanisms and seem to be
influenced by specific environmental cues that are independent of
general biofilm properties (Figs. 3 and 4) [52].
Physicochemical gradients have previously been demonstrated
in microbial biofilms [9,10]. However, little is known about how
these gradients affect the behavior of the cells integrated in the
biofilm structure. The specific signals regulating the formation of
the colistin tolerant subpopulation in E.coli are currently unknown,
but since the development is under control of the basR/basS two-
component system, it is probable that local environmental stimuli
affect the cells in the biofilms. It is known that media with low
Mg2+ in combination with high Fe
3+ ion concentrations activate
this regulatory network in vitro (Fig. 5B) [34]. We find it unlikely
that such conditions prevail inside the large micro-colonies under
the conditions tested. Luria broth is a medium with relatively low
Mg2+ levels, but no extra iron is added in the experiments making
it difficult to imagine a local accumulation of this ion in the micro
colonies in sufficient amounts to induce basS activation. The
magnesium ion concentration in the minimal medium used in flow
chamber experiments is sufficiently high to prevent basS dependent
induction, even in high iron conditions in a non biofilm setting and
it is therefore unlikely that differential magnesium iron concen-
tration is responsible for the observed induction [33]. The close
proximity of the cells in the larger micro colonies in biofilm
communities may create conditions mimicking the in vitro effect of
high iron levels. The bacteria may have to undergo complex
physiological adaptations in response to the consequences of the
high cell density within the micro-colonies. It is interesting to note,
that the homologous operon to the yfbE, the pmrH operon in
Salmonella typhimurium is induced during swarm-cell differentiation,
and an increased tolerance of swarmer cells to peptide antibiotics
have been found to be due to an altered phenotypic state of the
cells, in the absence of genetic changes [55,56]. It is possible that
the conditions within the organized microcolonies mimic those
that induce swarm-cell development. In addition, it cannot be
ruled out that the basR/basS are components of a general stress
response to toxic compounds produced by the metabolism of the
cells in the micro-colonies.
The data presented here suggest that biofilm mediated
antibiotic tolerance may often be a matter of subpopulation
differentiation within the biofilm. The basis for tolerance
development is not the biofilm formation per se, but that the
spatial and environmental heterogeneity provided by structurally
organized biofilms have the capacity to promote tolerant
subpopulation formation. In our experimental system, the
increased antibiotic tolerance exhibited by biofilm formation is
antibiotic specific and conditional, dependent on the actual biofilm
structure and on the presence of a specific genetically encoded
tolerance mechanism. Our data even suggest that specific modes
of biofilm organization may induce antibiotic tolerance, and that
the factors determining the properties of heterogeneous aggregat-
ed microbial communities may act on the individual cells within
the structures rather than on the community. No heritable genetic
changes are involved in the phenomenon; we suggest that many
other cases of biofilm-induced tolerance to antibiotics could be the
result of similar mechanisms. The biofilm mode of growth does not
directly predict antibiotic resistance and we suggest that a
complete elucidation of bacterial biofilm antibiotic tolerance
phenomena merits investigations that are not limited by
preconceived assumptions of the consequence of biofilm forma-
tion.
Materials and Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains relevant to this study are listed in Table 1.
Plasmids and PCR primers used in the study are listed in Table 2.
Except where indicated, the strains used are derivatives of E. coli
K-12 strain MG1655 or CSH26. Luria–Bertani (LB) broth or agar
[54] was used for standard cultivation supplemented with 0.2%
glucose. Appropriate antibiotics were added at the following final
concentrations 100 mgm l
21 ampicillin (Amp), 10 mgm l
21 chlor-
amphenicol (Cm), 100 mgm l
21 nalidixic acid (Nal) and
50 mgm l
21 kanamycin (Km) when required.
Genetic techniques and mutant construction
Unless otherwise stated all genetic methods followed standard
procedures as described by Ausubel, F.M., and others [53]. E. coli
phage P1 transductions were performed by the method of Miller
[57]. To enable conjugative plasmid transfer a spontaneous
nalidixic acid resistant mutant of MG1655 was isolated on LB agar
plates containing 10 mgm l
21 nalidixic acid at 37uC and
designated AF504. Conjugations of pAR108 pOX38-traD411
and pOX38-traX482 into AF504 from were performed by plate
mating [58] with SAR18/pAR108, SAR18/pOX38-traD411
pSK410 and SAR18/pOX38-traX482 as respective donors. The
defined insertion mutations in basS and basR were produced by
using one-step allelic replacement utilizing the l Red recombinase
Biofilm Antibiotic Tolerance
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recombinase plasmid pKD46 were grown in 5 ml SOB cultures
with ampicillin and L-arabinose at 30uC. pKD46 shows
temperature-sensitive replication and the Red recombinase genes
are under the control of a arabinose sensitive promoter. The
culture was grown to an OD600 of approximately 0.6 and then
made electro-competent by washing four times in ice-cold 15%
glycerol. PCR products were polymerase chain reaction (PCR)-
amplified via the Expand High Fidelity System (Roche) on a
Biometra T3 thermocycler using the plasmids pKD4 and pKD3 as
templates for kanamycin resistant and chloramphenicol resistant
insertions respectively. The amplified products were gel-purified,
digested with DpnI, repurified and suspended in water. Electro-
poration was performed by using a Gene pulser (Bio-Rad) as
recommended by the manufacturer using 50 ml bacterial cells and
10–100 ng PCR product. The cells were then added to 1 ml of
SOC medium [53] and incubated for 1 h at 37uC and then one-
half was spread onto selective agar plates. After primary selection,
putative mutants were re-streaked on selective media at 37uC and
then tested for ampicillin sensitivity. Putative insertion mutations
were transduced with phage P1 into fresh AF504 background for
further phenotypic characterization. The primers basSmutf and
basSmutr were used for allelic replacement. Insertions were
verified by PCR. The cloning of the full-length basRS genes and
yfbE promoter region, the primers ecoBasR1, xbaBasS1 and
yfbEco, yfbExba were used, respectively. The primers contain an
EcoRI restriction site or an XbaI for site to facilitate insertion in
the corresponding restriction sites on the gfp expression vector
pJBA113. The amplification was performed as described above for
the mutagenesis PCR. The PCR fragment was inserted into the
corresponding sites in the multiple cloning site of plasmid
pJBA113 and electroporated into E. coli XL10 (Stratagene),
resulting in the transcriptional GFP reporter plasmids pBASrs
and pYFBE32. DNA extraction, treatment with modifying
enzymes and restriction endonucleases, ligation of DNA fragments
with T4 ligase and transformation of E. coli was performed using
standard methods [53]. Plasmid DNA was isolated with the Spin
Miniprep Kit (Qiagen). DNA fragments agarose gel purified using
GFX DNA Purification system (Amersham Pharmacia Biothech).
Insertion of gfpmut3* under the rrnBP1 promoter in the attB site
E.coli AF504 was performed using a vector system previously
described [59]. The pLDR11 vector was digested with NotI
endonuclease, dephosphorylated and the 1.8 kb fragment
containing the bla gene and the lambda attP attachment site was
isolated. This fragment was ligated with a NotI fragment of
pSM1690. Competent E. coli cells carrying transformants were
selected at 42uC.
Microtitre plate biofilm and antibiotic tolerance assays
Biofilm formation and antibiotic tolerance was quantified using
the static microtiter plate biofilm assay. Bacterial cultures of the
investigated strains were grown in 5ml LB in 37uC to turbidity.
The cultures were diluted 1:300 and inoculated in triplicate in a
96-well microtiter plate (V-bottom; BioSterilin). Test plates were
transferred to plastic bags to avoid evaporation and statically
incubated for 24 h at 37uC. Biofilm formation was assayed by
staining of attached cells with crystal violet as described [60]. In
short, the growth medium was carefully removed from the biofilm
microtiter wells, washed twice with 0.9% NaCl solution, and
covered with 0.1% CV for 15 min. The wells were again washed
twice with 0.9% NaCl where after surface bound CV was
extracted by addition of 96% ethanol. Absorbance of stained wells
was determined at 590 nm with a VICTOR
2 multilabel counter
(Perkin Elmer, Inc.). For the antibiotic tolerance microtiter assay,
biofilms were grown in microtitre plates without antibiotics as for
biofilm quantification. After the 24 h incubation, colistin (H.
Lundbeck, Copenhagen) or ciprofloxacin (Bayer) was carefully
added to the wells at the indicated concentrations. After 24 h static
additional incubation cells were vigorously re-suspended and the
total CFUs were determined by serial dilution and plating on LB
plates without prior washing. Consistent removal of the bacterial
cells was confirmed by crystal-violet staining of the wells. For
microtitre biofilm assays and tolerance assay the data is presented
as mean6S.E.M. of 3 experiments performed in triplicate. In
parallel with each biofilm experiment, a microtiter plate MIC was
determined for the planktonic cells in the culture used as the
inoculum. That the biofilm-associated cells truly were dispersed to
single cells by vigorous aspiration was ascertained by observing the
dislodged biofilm under a microscope prior to plating.
GFP Expression Assay and yfbE expression visualization
Strains harboring the plasmids pYFBe32 were grown in N-
minimal media, pH 7.7, containing 38 mM glycerol with either
10 mM MgCl2,o r1 0 mM MgCl2 and 100 mM FeSO4 and
supplemented with 50 mg/ml ampicillin. GFP expression was
analyzed after 6h of growth at 37uC by using a fluorescence-
activated cell sorter (Becton Dickinson FACS Vantage SE). Assays
were performed in triplicate. For yfbE expression in biofilms,
strains were inoculated in 96 well microtiter plates as described for
the antibiotic tolerance assay. After incubation for 24 h at 37uC
Table 2. Plasmids and primers used in this study.
Plasmids Description Reference
pAR108 pOX38Km aph::cat-PA1/04/03-cfp* [6]
pOX38-traD411 pOX38 traD:: kan [64]
pOX38-traQ238 pOX38 traQ::kan [65]
pOX38-traX482 pOX38 traX::kan [24]
pSK410 F traD in pMS470D8 [66]
pSM1690 pLOW2 NotI-rrnBP1::gfpmut3b* [31]
pKD3 Chloramphenicol insertion template. [29]
pKD4 Kanamycin insertion template. [29]
pKD46 Red recombinase encoding plasmid [29]
pLDR8 int gene expression helper vector [59]
pLDR11 Cloning vector for attB integration [59]
pJBA113 Apr,pUC18Notl-PA1/04/03-RBSII-gfp(ASV)-
T0-T1a
[67]
pYFBe32 Derivative of pJBA113 carrying PyfbE PCR
fragment
This work
pBASrs2 Derivative of pJBA113 carrying basRS
fullength PCR fragment
This work
Primers Description Reference
basSmutf TCCCCGCATTTACTCTCATCAATACCTGGT-
CCTTCAGTGTAGGCTGGAGCTGCTTC
This work
basSmutr TCTGCGCCGACCAATATCGCTGCGCCAACGGC-
TGATATGGGAATTAGCCATGGTCC
This work
ecoBasR1 ATATAAGAATTCCTGTGGAATGACAACGATGG This work
xbaBasS1 AATTAATCTAGAAATATTTCGGTGCTGGTTGC This work
yfbEeco AATTAAGAATTCGAGCGGCAAAAAGCTAACAC This work
yfbExba ATATAATCTAGAGGGAAGGCGTAATCACTTCA This work
doi:10.1371/journal.pone.0001891.t002
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and GFP fluorescent monitored in the FACS. Strains harboring
the attB::bla-rrnBP1::gfpmut3b (GFP constitutive) and the pJBA113
vector alone (WT no reporter) demonstrated constitutive fluores-
cence and no fluorescence in all growth conditions, respectively.
The threshold for GFP fluorescence was set as cells with a value
above 600 arbitrary units. 99% of the constitutively expressing
cells were above this threshold while 96% of the negative control
was below. Experiments were done in triplicate. For visualization
of yfbE expression in the hydrodynamic flow chamber systems the
non-GFP fluorescent cells were counterstained with SYTO62
(Invitrogen) according to the manufacturers instructions.
Bacterial viability assay and fluorescence-activated cell
sorting
The LIVE/DEAD Baclight bacterial viability kit (Invitrogen)
was used to for distinguishing live and dead bacteria after
antibiotic treatment according to the manufacturers instructions.
For the biofilm experiments fluorescence-tagged bacteria (GFP)
and red-fluorescent propidium iodide (PI) staining were used. Red
fluorescing and green fluorescing cells from a colistin-treated
biofilm were sorted by fluorescence-activated cell sorting (Becton
Dickinson FACS Vantage SE) and plated on Luria Bertani plates
to verify that red fluorescing cells were not viable and green
fluorescing cells were viable.
Flow chamber biofilms
Cultivation of biofilms in laminar flow was done at 30uCa s
previously described [6]. Flow channels irrigated with AB minimal
medium [61] supplemented with 0.01 mM Fe-EDTA, 1.0 mg/ml
thiamine,or 1.0 mg/ml proline and uracil, where appropriate.
The channels were inoculated with 250 ml of normalized dilutions
(optical density at 600 nm of 0.05) of saturated bacterial cultures.
After 24h incubation, biofilms were challenge with 50 mg/ml,
25 mg/ml or 10 mg/ml colistin for an additional 24h where after
the bacterial red fluorescent viability stain propidium iodide was
injected into the flow channels and incubated for 15 min.
Images acquisition and analysis
All microscopic observations were performed by a Zeiss
LSM510 Confocal Laser Scanning Microscope, CLSM (Carl
Zeiss, Jena, Germany) equipped with an argon/krypton laser and
detectors and filter sets for simultaneous monitoring of GFP
(excitation 488 nm, emission 517 nm) and red-fluorescents
emitted from the PI (excitation 543nm, emission 565 nm). For
the quantification of biofilms and analysis of living and dead cells
in treated biofilms the software COMSTAT was used [62]. Images
were obtained using a 406/1.3 Plan-Neofluar oil objective.
Multichannel simulated fluorescence projection (SFP, a shadow
projection) images and vertical cross sections through the biofilm
were generated by using the IMARIS software package (Bitplane
AG, Zu ¨rich, Switzerland) running on a PC. Images were further
processed for display by using Photoshop software (Adobe,
Mountain View, Calif.). Time series experiments were performed
on the Zeiss LSM510 microscope and movie sequences were
produced using the Jasc software, Animation Shop 3. For the
quantification of E. coli F+ wild type and the different mutants
three independent biofilm experiments were performed acquiring
at least 9 image stacks for each strain and situation/time point
randomly down through the flow channel using a 40x/1.3 Plan-
Neofluar oil objective. For the quantification of living and dead
cells, each strain was grown in three channels in three independent
experiments, and from each experiment six image stacks were
acquired randomly in the channel. Images were further treated
using COMSTAT [62].
Statistical analysis
Statistical significance was determined using unpaired Student’s
t-test, values of P,0.05 were considered significant.
Supporting Information
Movie S1 E.coli flow-chamber biofilms are sensitive to the
cationic antimicrobial peptide colistin. Time series showing killing
dynamic of a mature AF504 gfp/F
+ biofilm. Staining of the biofilm
with PI (red) before/during image acquisition for monitoring of
dead cells. Images were acquired every 15 min for 42 h.
Found at: doi:10.1371/journal.pone.0001891.s001 (7.65 MB
MPG)
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